Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
基本信息
- 批准号:10718104
- 负责人:
- 金额:$ 73.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:APP-PS1AccelerationAddressAdrenergic AgentsAdverse effectsAffectAge MonthsAgingAirAir PollutionAlzheimer like pathologyAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease related dementiaAmyloid beta-ProteinAnimal ModelAstrocytesBehavioralBlood VesselsBrainCellsCerebrospinal FluidCervicalChemistryCognitive deficitsCranial NervesDedicationsDepositionDevelopmentDiameterDiseaseDisease ProgressionExhibitsExposure toFunctional disorderGeneticHumanHuman Amyloid Precursor ProteinImpaired cognitionInflammationInflammatoryInhalationInhalation ExposureIntercellular FluidLinkLiquid substanceMapsMeningealModelingMolecularMusNeurobiologyOrganismOxidative StressParticulate MatterPathologicPathologyPathway interactionsPatternPlayProcessProteinsResolutionRiskRodentRodent ModelRoleScanningSignal TransductionSleepSleep disturbancesSpinal nerve structureSubarachnoid SpaceSystemTestingTimeTissuesToxic Environmental SubstancesToxicologyTransgenic OrganismsTransmission Electron MicroscopyVenousWaste ProductsWild Type Mouseabeta depositionagedbioprocessbrain healthbrain parenchymabrain tissuecognitive performancecomorbiditydementia riskexperimental studyfluid flowglymphatic clearanceglymphatic dysfunctionglymphatic functionglymphatic systemhuman modelimprovedinnovationinterdisciplinary approachlymphatic vesselmouse modelmutantnervous system disorderneuroinflammationoverexpressionpharmacologicpresenilin-1regenerativeresponsesleep qualitysystemic inflammatory responseultrafine particlewastingwater channelwhite matter
项目摘要
Environmental toxicants and, more specifically, exposure to ambient particulate matter (PM) air pollution
increases the risk of developing Alzheimer's Disease (AD) and AD-Related Dementias (ADRD). Yet, our current
understanding of the mechanisms by which PM exposure augments the progression of ADRD-related pathology
and cognitive impairment is very limited. We posit that airborne ultrafine particles (UFP, <100 nm diameter) are
causally related to the development or progression of AD/ADRD. The glymphatic pathway is emerging as a key
to maintaining brain health and its dysfunction is implicated in several neurological disorders. This glial-
dependent clearance pathway is dedicated to draining soluble waste proteins and its existence has been
documented in the brain of multiple species, including humans. The proposal is based on preliminary studies
showing that exposure to model UFP significantly suppresses glymphatic fluid transport and increases the β
amyloid load in a murine model of AD pathology. We hypothesize that airborne UFP are transported to the
brain upon inhalation exposure and cause both systemic and neuroinflammation, thus either indirectly
or directly impairing glymphatic fluid flow and accelerating AD/ADRD-like pathology and behavioral
deficits in a mouse model of AD. The proposed aims will test our hypothesis by addressing the following
questions: Aim 1: How does short (3 days) or repeated (3 months intermittent) exposure to UFP affect glymphatic
fluid transport and cognitive performance in young (3 months) and aged (15 months) wildtype mice? Aim 2: Can
glymphatic impairment resulting from UFP exposure change the progression of Aβ deposition in a murine
AD/ADRD model? Aim 3: Will UFP accumulate and interact with cells along the major glymphatic fluid transport
segments? We will here use high-resolution analytical scanning transmission electron microscopy to analyze
precisely where in the brain parenchyma the UFP accumulate and interact. Aim 4: We will explore the molecular
mechanisms of UFP exposure-related glymphatic impairment and pathological progression in a murine
AD/ADRD model via pharmacological inhibition of adrenergic signaling. Moreover, a detailed study of AQP4
vascular polarization response to air particulate matter exposure, sleep disruption and how do adrenergic
inhibition reverse these signatures of pathology, would also be explored? The innovative aspects of the proposal
build upon a unique multidisciplinary approach where expertise in particulate matter toxicology (Elder), basic
and applied chemistry with particular focus on the study of UFP in living systems (Graham), neurobiology of
diseases and regenerative mechanisms (Hussain), and fundamentals of waste products and metabolites
clearance (Nedergaard), will be combined to address the question if and how do UFP enter, distribute,
accumulate, and ultimately undergo bioprocessing and efflux from the brain.
The proposed experiments represent the first fundamental analysis and mechanistic underpinning of the
interconnection between PM exposure, glymphatics, inflammation, and ADRD initiation and progression.
环境毒物,更具体地说,暴露于环境颗粒物 (PM) 空气污染
增加阿尔茨海默病 (AD) 和 AD 相关痴呆症 (ADRD) 的风险,但我们目前正在发展中。
了解 PM 暴露促进 ADRD 相关病理进展的机制
我们认为空气中的超细颗粒(UFP,直径<100 nm)是非常有限的。
与 AD/ADRD 的发生或进展有因果关系的类淋巴通路正在成为关键。
维持大脑健康及其功能障碍与多种神经系统疾病有关。
依赖性清除途径致力于排出可溶性废蛋白,其存在已被证实
该提议基于初步研究,记录在包括人类在内的多个物种的大脑中。
显示接触模型 UFP 显着抑制类淋巴液转运并增加 β
AD 病理学小鼠模型中的淀粉样蛋白负荷我们认为空气中的 UFP 正在运输到大脑。
吸入暴露后会进入大脑并引起全身和神经炎症,因此间接
或直接损害类淋巴液流动并加速 AD/ADRD 样病理和行为
AD 小鼠模型中的缺陷 所提出的目标将通过解决以下问题来检验我们的假设。
问题: 目标 1:短期(3 天)或重复(间歇性 3 个月)接触 UFP 如何影响类淋巴系统
年轻(3 个月)和老年(15 个月)野生型小鼠的液体运输和认知表现 目标 2:可以吗?
UFP 暴露导致的类淋巴系统损伤改变了小鼠体内 Aβ 沉积的进展
AD/ADRD 模型?目标 3:UFP 会沿着主要的类淋巴液运输积累并与细胞相互作用吗?
我们在这里将使用高分辨率分析扫描透射电子显微镜来分析
UFP 在脑实质中的精确积累和相互作用目标 4:我们将探索分子机制。
小鼠 UFP 暴露相关的类淋巴损伤和病理进展的机制
通过药物抑制肾上腺素信号传导的 AD/ADRD 模型此外,还对 AQP4 进行了详细研究。
血管极化对空气颗粒物暴露、睡眠中断的反应以及肾上腺素能如何
抑制逆转这些病理特征,是否也将探讨该提案的创新方面?
建立在独特的多学科方法的基础上,其中包括颗粒物毒理学(Elder)、基础
和应用化学,特别关注生命系统中 UFP 的研究(格雷厄姆),神经生物学
疾病和再生机制(Hussain),以及废物和代谢物的基础知识
许可(Nedergaard),将被合并以解决 UFP 是否以及如何进入、分发、
积累,并最终经过生物处理并从大脑中流出。
所提出的实验代表了第一个基本分析和机械基础
PM 暴露、类淋巴系统、炎症和 ADRD 发生和进展之间的相互关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alison Elder其他文献
Alison Elder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alison Elder', 18)}}的其他基金
International Nanotoxicology Congress: Nanotox 2016
国际纳米毒理学大会:Nanotox 2016
- 批准号:
9195226 - 财政年份:2016
- 资助金额:
$ 73.39万 - 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
- 批准号:
8502926 - 财政年份:2013
- 资助金额:
$ 73.39万 - 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
- 批准号:
9065942 - 财政年份:2013
- 资助金额:
$ 73.39万 - 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
- 批准号:
8852615 - 财政年份:2013
- 资助金额:
$ 73.39万 - 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
- 批准号:
8731894 - 财政年份:2013
- 资助金额:
$ 73.39万 - 项目类别:
Impact of Ambient Ultrafine Particle Exposures on Alzheimer's Disease Progression
环境超细颗粒暴露对阿尔茨海默病进展的影响
- 批准号:
9278171 - 财政年份:2013
- 资助金额:
$ 73.39万 - 项目类别:
Hazard Assessment and Risk Estimation of Inhaled Nanomaterials Exposure
吸入纳米材料暴露的危害评估和风险评估
- 批准号:
7852941 - 财政年份:2009
- 资助金额:
$ 73.39万 - 项目类别:
Hazard Assessment and Risk Estimation of Inhaled Nanomaterials Exposure
吸入纳米材料暴露的危害评估和风险评估
- 批准号:
7939792 - 财政年份:2009
- 资助金额:
$ 73.39万 - 项目类别:
Hazard Assessment and Risk Estimation of Inhaled Nanomaterials Exposure
吸入纳米材料暴露的危害评估和风险评估
- 批准号:
8071680 - 财政年份:2009
- 资助金额:
$ 73.39万 - 项目类别:
Fate and Effects of Nanoparticles: Relationship to Physicochemical Properties
纳米颗粒的命运和影响:与理化性质的关系
- 批准号:
7341306 - 财政年份:2007
- 资助金额:
$ 73.39万 - 项目类别:
相似国自然基金
高功率激光驱动低β磁重联中磁岛对电子加速影响的研究
- 批准号:12305275
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
U型离散顺流火蔓延非稳态热输运机理与加速机制研究
- 批准号:52308532
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
实施科学视角下食管癌加速康复外科证据转化障碍机制与多元靶向干预策略研究
- 批准号:82303925
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TWIST1介导的ITGBL1+肿瘤相关成纤维细胞转化加速结肠癌动态演化进程机制及其预防干预研究
- 批准号:82373112
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
NOTCH3/HLF信号轴驱动平滑肌细胞表型转化加速半月板退变的机制研究
- 批准号:82372435
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Role of adolescent stress in the acceleration of Alzheimer's disease related-cognitive impairment
青少年压力在加速阿尔茨海默病相关认知障碍中的作用
- 批准号:
10494601 - 财政年份:2022
- 资助金额:
$ 73.39万 - 项目类别:
Impact of the Human Herpesvirus 6A (HHV6A) latency gene U94A on Alzheimer disease pathology
人类疱疹病毒 6A (HHV6A) 潜伏基因 U94A 对阿尔茨海默病病理学的影响
- 批准号:
10617825 - 财政年份:2021
- 资助金额:
$ 73.39万 - 项目类别:
Microbial therapy improves gut permeability to reduce cognitive decline and Alzheimer’s disease
微生物疗法可改善肠道通透性,从而减少认知能力下降和阿尔茨海默病
- 批准号:
10185582 - 财政年份:2021
- 资助金额:
$ 73.39万 - 项目类别:
Role of Adaptive Myelination in Auditory Brain Plasticity
适应性髓鞘形成在听觉脑可塑性中的作用
- 批准号:
10713730 - 财政年份:2021
- 资助金额:
$ 73.39万 - 项目类别: